Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep592 | Endocrine-related Cancer | ECE2023

Ferroptosis in human adrenocortical cells and aldosterone-producing adenomas

Pang Yingxian , Tetti Martina , Gong Siyuan , Reincke Martin , Ann Williams Tracy

Background: The role of ferroptosis – a regulated form of cell death – in the pathophysiology of aldosterone-producing adenomas (APA) is unclear.Objective: To identify mechanisms of ferroptosis in human adrenal cells and translate these findings to APA pathophysiology.Methods: Cell death detection, lipid ROS generation and mRNA sequencing were performed on HAC15 cells treated with the specific ferroptosis inducer RSL3 (1,...

ea0070aep19 | Adrenal and Cardiovascular Endocrinology | ECE2020

Genes mediating cell growth in aldosterone-producing adenomas

Yang Yuhong , Tetti Martina , Mulatero Paolo , Schneider Holger , Reincke Martin , Ann Williams Tracy

Objective: Aldosterone-producing adenomas (APA) are a major cause of primary aldosteronism. Somatic mutations explain the excess aldosterone production in the majority of patients with APA with mutations in KCNJ5 encoding a potassium channel the most prevalent in most reported populations. Mechanisms driving cell proliferation are largely undefined.Design and method: Quantitative transcriptome analysis using RNA-seq was used to identify differen...

ea0063gp104 | Adrenal and Neuroendocrine - Basic | ECE2019

Identification of genes mediating dysregulated cell growth in aldosterone-producing adenomas

Yang Yuhong , Tetti Martina , Jaquin Diana , Mulatero Paolo , Schneider Holger , Beuschlein Felix , Reincke Martin , Williams Tracy Ann

Background: Aldosterone-producing adenomas (APA) are a major cause of primary aldosteronism. Somatic mutations explain the excess aldosterone production in the majority of patients with APA with mutations in the potassium channel KCNJ5 the most prevalent. In contrast, mechanisms driving cell proliferation are largely unresolved.Objective: To identify genes that modulate cell growth in APAs.Methods: Quantitative transcripto...

ea0094oc5.1 | Adrenal and Cardiovascular | SFEBES2023

Urine steroid metabolomics as a diagnostic tool in endocrine hypertension

Prete Alessandro , Abdi Lida , Suntornlohanakul Onnicha , Lang Katharina , Riancho Julien , Lazkani Aida , Larsen Casper K. , Gimenez-Roqueplo Anne-Paule , Pecori Alessio , Tetti Martina , Monticone Silvia , Muller Lisa M. , Adolf Christian , Timmers Henri J.L.M. , Hampson Stephanie , Eisenhofer Graeme , Ceccato Filippo , Beuschlein Felix , Kabat Marek , Bertherat Jerome , Dennedy Conall , Davies Eleanor , Deinum Jaap , Reincke Martin , Paolo Rossi Gian , Mulatero Paolo , Amar Laurence , Zennaro Maria-Christina , Sitch Alice J. , Tino Peter , Biehl Michael , Taylor Angela E. , Arlt Wiebke

Background: Hypertension affects more than 30% of the adult population worldwide and is a major cardiovascular risk factor. Identifying secondary causes of hypertension is key to offering targeted treatment and mitigating adverse health outcomes. We tested the performance of urine steroid metabolomics (USM), the computational analysis of 24-hour urine steroid metabolome data by machine learning, for diagnosing endocrine hypertension.<str...